Drawing for TRUCAD

USPTO serial 87594368

TRUCAD

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
THOMAS-RIGGS, LESLIE A
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TRUCAD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Seth Rappaport

Seth Rappaport MORGAN, LEWIS & BOCKIUS LLP1111 PENNSYLVANIA AVENUE, NWATTENTION: TMSUWASHINGTON, DC 20004-2541

Goods and services

ClassDescriptionStatusFirst use
010Medical diagnostic blood testing apparatus for use in the field of coronary artery disease; Medical test kits in the field of coronary artery disease consisting primarily of a blood collection tube containing a preservative, a set of reagents for purifying RNA, a set of primers and probes for quantifying transcript levels, and related computer software featuring an algorithm for computing risk of coronary artery disease sold as a unit for home use and for use by medical practitioners in the diagnosis of Atherosclerotic burden; medical devices for diagnosing coronary artery diseaseACTIVE
042Research services in the field of medicine, namely, scientific research services and medical researchACTIVE
044Medical services, medical testing of blood, medical testing for diagnostic purposes, medical testing, namely, coronary artery disease (CAD) testing for diagnostic or treatment purposes, medical assessment services, namely, providing coronary and vascular risk assessment for diagnostic or treatment purposes, stroke risk assessment for diagnostic or treatment purposes, Atherosclerotic load risk assessment for diagnostic or treatment purposes, aneurysm risk assessment for diagnostic or treatment purposes, and peripheral vascular disease risk assessment for diagnostic or treatment purposes; providing medical advice, namely, providing guidance for hypercholesterolemia treatment; medical analysis for the treatment of coronary artery disease (CAD); healthcareACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 7, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 7, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 27, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 26, 2020EX5GSOU EXTENSION 5 GRANTED
Oct 24, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 15, 2020EXT5SOU EXTENSION 5 FILED
Oct 15, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 30, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 28, 2020EX4GSOU EXTENSION 4 GRANTED
Apr 28, 2020EXT4SOU EXTENSION 4 FILED
Apr 28, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 18, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 16, 2019EX3GSOU EXTENSION 3 GRANTED
Oct 16, 2019EXT3SOU EXTENSION 3 FILED
Oct 16, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 1, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 29, 2019EX2GSOU EXTENSION 2 GRANTED
Apr 29, 2019EXT2SOU EXTENSION 2 FILED
Apr 29, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 19, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 17, 2018EX1GSOU EXTENSION 1 GRANTED
Oct 17, 2018EXT1SOU EXTENSION 1 FILED
Oct 17, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 1, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 6, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 6, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 14, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2018ALIEASSIGNED TO LIE
Jan 18, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 10, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jan 9, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 9, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 14, 2017GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 14, 2017GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 14, 2017CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 7, 2017DOCKASSIGNED TO EXAMINER
Sep 10, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 5, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance